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Abstract
Background: Microbial exposures early in life have been found to be associated with lower levels of inflammation
in adulthood; however, the role of prenatal exposure to infection on offspring inflammatory profiles is unexplored.
The aim was to study if maternal infections during pregnancy are associated with inflammation among offspring in
later life and to determine if there are sensitive periods of exposure.
Methods: The study was comprised of 1719 participants in the Copenhagen Aging and Midlife Biobank (CAMB)
who were also members of the Copenhagen Perinatal Cohort (CPC). When the CPC was established, information on
maternal infections during pregnancy was prospectively collected by a trained medical doctor. The inflammatory
measures collected in late midlife included, C-reactive protein (CRP), Interleukin-6 (IL-6), TNF-alpha (TNF-α) and
Interleukin-10 (IL-10). Multivariable ordinary least squared regression models were implemented to explore
associations between maternal infection and inflammatory measures in offspring, controlling for maternal smoking,
pre-pregnancy body mass index, age, marital status and parity.
Results: Maternal infection was associated with a 7% lower CRP level (95% CI, − 17,5%) among offspring compared
with offspring born to women without an infection and similarly an 8% lower level of IL-6 (95% CI -15,1%), and a
9% lower level of IL-10 (95% CI, − 23,20%). However, differences did not reach significance. The effects of infection
during the first trimester did not differ from infections later in the pregnancy.
Conclusions: Our results suggested that prenatal exposure to infection may be associated with lower levels of
inflammatory markers among adult offspring. Additional prospective studies are needed to further explore this
finding.
Keywords: Infection, Inflammation
Background
Recent studies indicate that chronic inflammation is im-
plicated in a host of aging-related conditions [1–3], and
may be a mechanism that links early life exposures with
later health [4]. The prenatal and early environment may
influence the regulation of inflammation and inflamma-
tory phenotypes through the process of developmental
plasticity [5]. Developmental plasticity provides organ-
isms with the ability to change function and structure in
response to environmental cues such as early nutritional
and microbial exposures, typically during critical pe-
riods, such as the fetal period and infancy.
Maternal health may directly affect the fetal environment
through factors such as subclinical maternal inflammation
or even maternal infection or illness [6, 7]. Many common
maternal bacterial or viral infections such as urinary tract
and respiratory infections have been shown to be associated
with preterm birth [6]. Goldenberg et al. and Romero et al.
have shown that maternal inflammation exposed the fetus
to an increased expression of cytokines, chemokines and
lipid mediators through circulation, suggesting that com-
mon infections may play a role in the development of in-
flammation [8, 9]. To our knowledge, no previous studies
have investigated the association between maternal infec-
tions and inflammation among adult offspring.
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It is unclear how infections early in life affect later in-
flammation. The hygiene hypothesis posits that exposure
to infectious agents protects against a large spectrum of
disorders related to immune dysregulation, as evidenced
by increasing rates of the full spectrum of atopic ill-
nesses, which have risen in parallel to improved sanitary
conditions [10, 11]. In support of the hygiene hypothesis,
McDade et al. have shown that microbial exposures dur-
ing the first two years of life were associated with lower
levels of C-reactive protein (CRP) in adulthood [12].
This was the only observational study identified address-
ing the association between infant microbial exposures
and later inflammation. The aim of the current paper
was to study if maternal bacterial or viral infections dur-
ing pregnancy are associated with inflammation among
offspring in later life. Furthermore, we aimed to deter-
mine if exposure to infections during the first trimester
of pregnancy is a particular sensitive period in relation
to the inflammatory profile of offspring in late midlife.
Materials and methods
The study sample was comprised of participants in the
Copenhagen Aging and Midlife Biobank (CAMB) [13]
who were also members of the Copenhagen Perinatal Co-
hort (CPC). [14] The CPC consists of 9125 consecutive
deliveries by 8949 pregnant women giving birth at the
Copenhagen University Hospital from October 1959
through December 1961, with 8400 infants surviving the
first month after birth [14]. In 2009–2011, all CPC partici-
pants who were alive and living in eligible study areas (n
= 5196) were invited to participate in CAMB. A total of
1719 agreed to participate in the clinical examination, in-
cluding blood draw, constituting a 33% participation rate.
The CAMB received ethical approval from the Scientific
Ethics Committee Denmark (Protocol # H-A-2008-126).
A single physician was responsible for collecting ma-
ternal information through interviews with the mothers
at the first antenatal visit and five days following deliv-
ery. A bacterial infection was considered present if there
was a medical diagnosis and treatment was prescribed
by a medical practitioner. The following bacterial infec-
tions were recorded: sinusitis, tonsillitis, pneumonia,
cystitis, pyelonephritis, bacterial venereal infection or
other bacterial infection. A viral infection was judged
present if (1) a medical diagnosis was made by a general
practitioner or (2) symptoms consistent with minor re-
spiratory illness or influenza were present and accom-
panied by maternal bed rest and a temperature of ≥38 °
C. The time during pregnancy in which the infection oc-
curred was reported by trimester. We categorized infec-
tions as no infection during pregnancy versus any
number of viral or bacterial infections at any time dur-
ing pregnancy. To test our hypothesis that the first tri-
mester of pregnancy is a particular sensitive period in
relation to the inflammatory profile of offspring in late
midlife we further categorized the infection data as no
infection during pregnancy, having at least one infection
during the first trimester of pregnancy but not during
other periods, having at least one infection during the
second or third trimester of pregnancy but not the first
trimester, or having an infection in the first trimester
and in the second/and or third trimester in the preg-
nancy This analysis is based on 1705 participants with
available information on the timing of infections in
pregnancy.
CRP, IL-6, IL-10 and Tumor necrosis factor α (TNF-α)
were included in the current study. The inflammatory
markers were derived from non-fasting blood samples col-
lected at the CAMB in 2009 to 2011. Cytokines were mea-
sured in plasma with EDTA as the anticoagulant and
analyzed individually as continuous variables. High sensitiv-
ity CRP was analyzed by Roche/Hitachi MODULAR P, with
a measuring range of 0.1–20mg/L (0.95–190mmol/L at
the Clinic Biochemical Laboratory and IL-6, TNF-α and
IL-10 were analyzed in EDTA plasma by
electro-chemiluminiscence multiplex system on a Sector
2400 Imager at the Centre of Inflammation and Metabol-
ism, Rigshospitalet. The Lower limit of detection (LOD) for
IL-6 was 0.21 pg/ml and inter assay coefficient of variation
(CV) was 11 -21%. For IL-10 LOD =0.21 pg/ml and inter
assay CV was 15–28%. For TNF-α LOD was 0.28 pg/ml
and inter assay CV was 9 -13%. There were 0.4 and 6.5% of
values below the LOD for IL-6 and IL-10 respectively, and
these values were substituted using simple imputation.
Potential confounders include maternal age, parity,
maternal tobacco smoking during pregnancy, maternal
pre-pregnancy body mass index (BMI), derived from
self-reports of height and weight collected during preg-
nancy, and maternal marital status categorized as mar-
ried versus unmarried or other.
The inflammatory markers were analyzed as continuous
variables and transformed using the natural logarithm to
approach normality. Thus, regression coefficients can be
interpreted as the relative increase (factor) in the outcome
due to changes in the exposure. Crude linear regression
coefficients show the association between increases in
continuous covariate measures on the inflammatory
markers. Geometric means of the inflammatory markers
by categories of categorical covariates were performed. A
series of ordinary least squares regression models with in-
fections as the exposure and each inflammatory marker as
the outcome were performed. The first model adjusted for
maternal age at birth and parity, the second model add-
itionally adjusted for maternal smoking, pre-pregnancy
BMI and marital status. The same analyses stratified by
timing of the infection were also carried out. Missing data
was handled using a chained equation multiple imputation
model with 10 imputations [15].
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Results
The offspring were between the age of 49 and 53 years
at blood draw, 56% were female, the mean body mass
index was 26 (SD 4.7) and 30.6% had an upper second-
ary education with only 2% of participants reporting no
education. (results not shown) The mean age of the
mothers at conception was 26.7 (SD 6.6) and 23% had
an infection during pregnancy. Other baseline character-
istics are shown in Table 1. Characteristics of the study
population stratified by maternal infection during preg-
nancy are presented in Table 2. Maternal pre-pregnancy
BMI was not associated with any of the inflammatory
markers of interest and maternal age at birth was nega-
tively associated with CRP but not with the other in-
flammatory markers in a crude model (Table 3).
Increasing parity was positively associated with the in-
flammatory markers. Among women with an infection,
the geometric means of the offspring inflammatory
markers were lower than among women without an in-
fection. There were higher levels of inflammatory
markers among the offspring of women who were un-
wed at conception in comparison with married women,
particularly in CRP and IL-6. There were not consider-
able differences in offspring inflammatory levels among
smoking and non-smoking mothers or among males and
females, with the exception of higher levels of IL-10
among male (geometric mean = 4.66) vs. female (geo-
metric mean = 4.22) offspring.
Maternal infection during pregnancy was associated
with a 7% lower CRP level (among offspring compared
with offspring born to women without an infection (95%
CI, − 17,5%) and similarly an 8% lower level of IL-6 (95%
CI, − 15, 1%), and a 9% lower level of IL-10 (95% CI, −
23,20%) (Table 4). The confidence intervals are, however,
broad and we cannot statistically confirm these findings.
We did not find evidence of different effects during the
first trimester, compared with later in the pregnancy
(Table 3). For example, an infection only during the first
trimester was associated with a 8% lower level of IL-6
(95% CI -25, 14%), whereas an infection only during the
Table 1 Characteristics of Danish men and women with
continuous participation in the Copenhagen Perinatal Cohort
and the Copenhagen Aging and Midlife Biobank
N Mean (SD and r
ange)/percent
Maternal pre-pregnancy BMI (kg/m2)* 1616 21.7 (2.9; 14.7–47.8)
Maternal age at birth (years) 1709 26.7 (6.6; 14.6–48.1)
C-reactive protein 1692 2.35 (4.8; 0.01–108)
Interleukin-6 1689 2.7 (11.6; 0.01,442)
Interleukin-10 1681 8.9 (42; 0.01–509)
Tumor necrosis factor α 1691 5.3 (8.1; 0.65–208)
Parity
1 822 48
2 470 27
3 263 15
4 112 7
5+ 51 3
Infection during pregnancy
No 1313 77
Yes 392 23
Maternal civil status at conception
Married mother 1167 68
Unmarried mother 542 32
Tobacco smoking in pregnancy
No 892 52
Yes 801 47
Child’s gender
Male 753 44
Female 966 56
Means and standard deviations of continuous variables and frequency and
percent of categorical variables
BMI body mass index
Table 2 Characteristics of participants by exposure to prenatal
infection
No infection during
pregnancy
N = 1313
Infection during
pregnancy
N = 392
P-Value*
Maternal pre-pregnancy
BMI (kg/m2)
21.7 21.5 0.284
Maternal age at birth
(mean years)
26.8 26.3 0.191
Parity n (%)
1 622(47) 196 (50)
2 370 (28) 97 (25)
3 194 (15) 63 (16)
4 83 (6) 29 (7)
5+ 43 (3) 7 (2) 0.299
Maternal civil status
at conception n(%)
Married mother 889 (68) 275 (70)
Unmarried mother 422 (32) 117 (30) 0.382
Tobacco smoking
in pregnancy n(%)
No 674 (52) 203 (53)
Yes 615 (48) 183 (47) 0.917
Child’s gender n(%)
Male 742 (57) 217 (55)
Female 571 (43) 175 (44) 0.686
Means or geometric means and standard deviations are presented for the
continuous variables and number and percent for the categorical variables
together with p-values
*calculated with ANOVA for continuous variables and chi2 for
categorical variables
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Table 3 Crude linear regression coefficients showing the association between increases in continuous covariates on inflammatory markers
Continuous variables/Geometric mean
CRP IL-6 IL-10 TNF-α
Maternal pre-pregnancy BMI (kg/m2) 1.02 (1.00,1.03) 1.01 (1.00,1.02) 1.00 (1.00,1.01) 1.00 (0.97,1.02)
Maternal age at birth (years) 0.99 (0.98,0.99) 1.00 (0.99,1.00) 1.00 (1.00,1.00) 1.00 (0.99,1.01)
Parity
1 1.20 1.65 4.48 1.15
2 1.12 1.60 4.39 1.22
3 1.21 1.70 4.31 1.35
4 0.91 1.68 4.35 1.17
5+ 1.63 2.14 5.16 1.02
p-value for difference 0.06 0.01 0.09 0.56
Infection during pregnancy
No 1.20 1.68 4.44 1.22
Yes 1.09 1.54 4.39 1.12
p-value for difference 0.18 0.06 0.53 0.28
Maternal civil status at conception
Married mother 1.03 1.60 4.39 1.19
Unmarried mother 1.35 1.78 4.53 1.19
p-value for difference < 0.001 0.001 0.22 0.90
Tobacco smoking in pregnancy
No 1.13 1.63 4.39 1.22
Yes 1.21 1.68 4.48 1.15
p-value for difference* 0.25 0.45 0.27 0.42
Child’s gender
Male 1.15 1.67 4.66 1.22
Female 1.20 1.65 4.22 1.17
p-value for difference* 0.48 0.93 < 0.001 0.64
Geometric means by categories of categorical covariates with corresponding p-values
BMI body mass index, CRP C-reactive protein, IL-6 Interleukin-6, IL-10 Interleukin-10, TNF-α tumor necrosis factor-α, *p-values obtained using ANOVA
Table 4 Associations between maternal infection and timing of maternal infection during pregnancy and inflammatory markers
CRP IL-6 IL-10 TNF-α
Cases Crude
Factor
(95% CI)
Factor
(95% CI)*
Crude
Factor
(95% CI)
Factor
(95% CI)*
Crude Factor
(95% CI)
Factor
(95% CI)*
Crude
Factor
(95% CI)
Factor
(95% CI)*
Infection during pregnancy 392 0.93
(0.81,1.06)
0.93
(0.81,1.06)
0.92
(0.84,1.01)
0.92
(0.85,1.01)
0.91;(0.77,1.08) 0.91
(0.77,1.08)
0.99
(0.94,1.03)
0.99
(0.94,1.04)
Timing of infection
Never 1313 1 1 1 1 1 1 1 1
Trimester 1 55 1.04
(0.78,1.34)
1.05
(0.80,1.38)
0.88
(0.73,1.06)
0.90
(0.74,1.07)
0.95
(0.85,1.06)
0.95
(0.66,1.36)
0.95
(0.85,1.06)
0.95
(0.85,1.06)
Trimester 2 &/or 3
Trimester 1 & later in
pregnancy
317
20
0.90
(0.78,1.02)
0.90
(0.78,1.02)
0.90
(0.79,1.03)
0.90
(0.78,1.02)
0.92
(0.84,1.02)
0.90
(0.78,1.02)
0.93
(0.84,1.02)
0.90
(0.78,1.02)
0.99
(0.94,1.04)
0.90
(0.78,1.02)
0.91
(0.76,1.09)
0.90
(0.78,1.02)
0.99
(0.94,1.04)
0.90
(0.78,1.02)
0.99
(0.94,1.04)
0.90
(0.78,1.02)
The factors and 95% confidence intervals (CI) are presented. Analyses based on 1719 men and women with continuous participation in the Copenhagen Perinatal
Cohort and the Copenhagen Aging and Midlife Bioank
*Controlled for parity, maternal age, maternal pre-pregnancy BMI and smoking in the last trimester, maternal civil status, gender
BMI body mass index, CRP C-reactive protein, IL-6 Interleukin-6, IL-10 Interleukin-10, TNF-α tumor necrosis factor-α
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2nd or third trimester was associated with a 7% lower
level of IL-6 (95% CI, − 15,3%) and an infection in the first
trimester and later in pregnancy was associated with 29%
lower level of IL-6 (95% CI -49,0%) Adjustments for other
prenatal factors did not significantly affect the estimates.
Discussion
We found that increasing parity and being conceived by an
unmarried mother, which was potentially a maternal stres-
sor during pregnancy, were associated with higher levels of
inflammatory proteins in middle age. In accordance with
the hygiene hypothesis, our findings suggest that, with the
exception of TNF-α, maternal viral and bacterial infections
during pregnancy may be associated with lower levels of in-
flammation among adult offspring. We did not find evi-
dence of a sensitive period of exposure to infections during
the first trimester of pregnancy. The results, however, must
be interpreted with caution due to the wide confidence in-
tervals and insignificant estimates. In a previous study
based on a Filipino population, McDade and colleagues
found that higher levels of microbial exposure in infancy
were associated with lower CRP levels in early adulthood
[12]. They speculated that this finding might be due to early
microbial exposures contributing to the development of
anti-inflammatory regulatory networks representing plasti-
city in the development of anti-pathogen defenses [12]. The
findings of the current study suggest that exposure to infec-
tion during pregnancy, in addition to early microbial expo-
sures, may contribute to this plasticity.
To our knowledge, this is the first study of the associ-
ation between prenatal infections and offspring inflamma-
tory profiles in later life. Strengths of the study include the
prospective design, detailed information on the timing of
exposure and the ability to adjust for a number of poten-
tially important prenatal confounders. There are, however,
limitations; we do not have information about the severity
of the infection in pregnancy. It would have been valuable
to know if there were systemic signs of infection among
the mothers, such as fever or leukocytosis or if the infec-
tion was localized, as one could postulate that systemic ill-
ness may have a greater effect than localized infection.
The inflammatory markers were only measured at a single
occasion. Furthermore, only 33% of those invited to
CAMB participated in the clinical examination where
physical testing and blood samples were collected. A com-
parison of CAMB participants with non-participants in
Danish national registries suggests that non-participants
were significantly more likely to die in the years following
data collection than participants [15] suggesting that the
CAMB population was in better health and this may have
led us to underestimate the effect of prenatal infections on
later inflammation, particularly if non-participants were
also likely to have more prenatal infections than
participants.
Conclusion
We cannot make any definitive conclusions about the
findings in this study, but it appears that prenatal expos-
ure to infection may be associated with lower levels of
inflammatory markers among adult offspring. This must
be explored further in additional prospective studies,
with more detailed information about the severity and
type of infection.
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